Friday, October 20, 2017

=RedHill Biopharma (RDHL) : MESUPRON granted Orphan Drug designation

RedHill Biopharma confirms the FDA granted MESUPRON Orphan Drug designation for the adjuvant treatment of pancreatic cancer


No comments:

Post a Comment